If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGOG.L Regulatory News (GOG)

  • There is currently no data for GOG

Form 8.3 - Go-Ahead Group plc, The

10 Aug 2022 12:56

RNS Number : 5891V
Barclays PLC
10 August 2022
 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Barclays PLC.

(b)

Owner or controller of interest and short

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

GO-AHEAD GROUP PLC, THE

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

offeror/offeree, state this and specify identity of

offeror/offeree:

(e)

Date position held/dealing undertaken:

09 Aug 2022

(f)

In addition to the company in 1(c) above, is the discloser making

NO

disclosures in respect of any other party to the offer?

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

to which the disclosure relates following the dealing(if any)

Class of relevant security:

10p ordinary

Interests

Short Positions

Number

(%)

Number

(%)

(1)

Relevant securities owned

and/or controlled:

729,051

1.69%

62,977

0.15%

(2)

Cash-settled derivatives:

and/or controlled:

5,999

0.01%

405,011

0.94%

(3)

Stock-settled derivatives (including options)

and agreements to purchase/sell:

0

0.00%

0

0.00%

TOTAL:

735,050

1.70%

467,988

1.08%

(b)

Rights to subscribe for new securities (including directors and other executive

options)

Class of relevant security in relation to

which subscription right exists

Details, including nature of the rights

concerned and relevant percentages:

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

Class of relevant

Purchase/sale

Number of

Price per unit

security

securities

10p ordinary

Purchase

30

15.3500 GBP

10p ordinary

Purchase

50

15.3208 GBP

10p ordinary

Purchase

243

15.3400 GBP

10p ordinary

Purchase

504

15.3625 GBP

10p ordinary

Purchase

1,056

15.3371 GBP

10p ordinary

Purchase

2,407

15.3218 GBP

10p ordinary

Sale

11

15.3345 GBP

10p ordinary

Sale

26

15.3400 GBP

10p ordinary

Sale

163

15.3391 GBP

10p ordinary

Sale

169

15.3600 GBP

10p ordinary

Sale

1,460

15.3274 GBP

(b)

Cash-settled derivative transactions

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

reference

unit

security

securities

10p ordinary

SWAP

Long

5

15.3360 GBP

10p ordinary

SWAP

Long

6

15.3333 GBP

10p ordinary

SWAP

Long

26

15.3398 GBP

10p ordinary

SWAP

Long

169

15.3600 GBP

10p ordinary

SWAP

Long

713

15.3198 GBP

10p ordinary

SWAP

Long

747

15.3347 GBP

10p ordinary

SWAP

Short

120

15.3200 GBP

10p ordinary

SWAP

Short

383

15.3612 GBP

10p ordinary

CFD

Short

504

15.3625 GBP

10p ordinary

SWAP

Short

553

15.3251 GBP

(c)

Stock-settled derivative transactions (including options)

(i)

Writing, selling, purchasing or varying

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

date

money

relevant

selling,

securities

per unit

paid/

security

varying etc

to which

received

option

per unit

relates

(ii)

Exercising

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

securities

unit

(d)

Other dealings (including subscribing for new securities)

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

applicable)

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

to the offer or any person acting in concert with a party to the offer:

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

any derivative is referenced:

NONE

(c)

Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

10 Aug 2022

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETBBGDISUBDGDG
Date   Source Headline
9th Dec 20217:00 amRNSUpdate on LSER and FY21 Results Date
2nd Dec 20217:00 amRNSAppointment of Non-Executive Director
23rd Nov 20214:25 pmRNSEmployee Benefit Trust Share Purchase
17th Nov 20213:11 pmRNSNotice of AGM
16th Nov 20214:52 pmRNSDirector/PDMR Shareholding
8th Nov 20217:00 amRNSTrading Statement
27th Oct 20214:52 pmRNSHolding(s) in Company
26th Oct 202110:10 amRNSHolding(s) in Company
19th Oct 20215:06 pmRNSEmployee Benefit Trust Share Purchase
14th Oct 20214:44 pmRNSDirector/PDMR Shareholding
30th Sep 20219:44 amRNSHolding(s) in Company
28th Sep 20217:00 amRNSSoutheastern, Board change & Full year results
23rd Sep 20217:00 amRNSEmployee Benefit Trust Share Purchase
16th Sep 20217:00 amRNSDirector/PDMR Shareholding
27th Aug 20217:00 amRNSGo-Ahead Group: Full year results publication date
20th Aug 20212:28 pmRNSEmployee Benefit Trust Share Purchase
12th Aug 20215:03 pmRNSDirector/PDMR Shareholding
28th Jul 20219:30 amRNSHolding(s) in Company
22nd Jul 20217:01 amRNSGo-Ahead Group plc appoints new CEO
20th Jul 20214:06 pmRNSEmployee Benefit Trust Share Purchase
14th Jul 202111:41 amRNSDirector/PDMR Shareholding
7th Jul 20217:00 amRNSGo-Ahead welcomes further bus funding package
1st Jul 20219:58 amRNSBlock listing Interim Review
22nd Jun 202111:49 amRNSEmployee Benefit Trust Share Purchase
17th Jun 20217:00 amRNSGTR ERMA extension
16th Jun 20213:47 pmRNSDirector/PDMR Shareholding
14th Jun 20214:36 pmRNSHolding(s) in Company
10th Jun 20217:00 amRNSGo-Ahead trading update
26th May 20219:37 amRNSHolding(s) in Company
26th May 20217:00 amRNSGo-Ahead CEO David Brown to retire
21st May 20219:39 amRNSHolding(s) in Company
20th May 202112:39 pmRNSEmployee Benefit Trust Share Purchase
13th May 202110:41 amRNSDirector/PDMR Shareholding
30th Apr 20212:20 pmRNSHolding(s) in Company
21st Apr 20214:36 pmRNSHolding(s) in Company
21st Apr 202110:31 amRNSHolding(s) in Company
20th Apr 20213:31 pmRNSEmployee Benefit Trust Share Purchase
19th Apr 20215:22 pmRNSHolding(s) in Company
14th Apr 202112:14 pmRNSDirector/PDMR Shareholding
14th Apr 20219:20 amRNSHolding(s) in Company
9th Apr 20219:50 amRNSHolding(s) in Company
1st Apr 20215:27 pmRNSHolding(s) in Company
1st Apr 202111:02 amRNSHolding(s) in Company
30th Mar 20214:48 pmRNSHolding(s) in Company
23rd Mar 20212:23 pmRNSEmployee Benefit Trust Share Purchase
15th Mar 20215:11 pmRNSDirector/PDMR Shareholding
11th Mar 20215:43 pmRNSHolding(s) in Company
11th Mar 20217:00 amRNSThe Go-Ahead Group plc: Half year results
24th Feb 20211:37 pmRNSEmployee Benefit Trust Share Purchase
15th Feb 20213:36 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.